Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer.

Hanna GJ, Guenette JP, Chau NG, Sayehli CM, Wilhelm C, Metcalf R, Wong DJ, Brose M, Razaq M, PĂ©rez-Ruiz E, Cohen EEW, Aggarwal R, Scholz C, Gualberto A, Ho AL. Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer. Cancer. 2020 09 01; 126(17):3972-3981.

View in: PubMed

collapse authors with profiles